For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
Peter Lin |
Eva Hao |
Eva Hao |
02-87977607 |
9F.,No.20,9F.,No.22,Lane 478,Rueiguang Rd.Neihu District, Taipei,Taiwan,R.O.C. |
2012/09/13 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
Founded in Oct. 2005, INNOPHARMAX is a specialty pharmaceutical company
focused on developing and commercializing products for the treatment of
infectious diseases, immunology and oncology. One of our core technologies,
OralPAS®, is a SMEDDS-based drug delivery system technology to encapsulate
drug molecular within emulsified droplet keeping from hydrolysis in GI tract
to enhance oral absorption. We are developing the advanced drug delivery
technology platform for improving the safety and effectiveness for current
available drugs and providing better medical choices in these specific disease
categories. |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|